BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16900998)

  • 1. Myeloid metaplasia in aspirates from enlarged spleens: a clue in the absence of peripheral blood findings characteristic of myelofibrosis.
    Sen R; Bhadani PP; Singh H; Sachdeva B; Sen J; Singh S; Gupta M; Mehta K
    Acta Cytol; 2006; 50(4):379-83. PubMed ID: 16900998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid metaplasia presenting as a splenic mass: report of a case with fine-needle aspiration cytology.
    Austin GE; Giltman LI; Varma V; King Thompson N
    Diagn Cytopathol; 2000 Nov; 23(5):359-61. PubMed ID: 11074635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Splenic extramedullary hematopoiesis in myelofibrosis. Pathogenetic considerations apropos of a personally studied case].
    Piaserico PL; Piaserico GP
    Minerva Med; 1983 Oct; 74(39):2313-8. PubMed ID: 6657100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.
    Wolf BC; Neiman RS
    Blood; 1985 Apr; 65(4):803-9. PubMed ID: 3978228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic myelofibrosis accompanied by peritoneal extramedullary hematopoiesis presenting as refractory ascites in a dog.
    Rautenbach Y; Goddard A; Clift SJ
    Vet Clin Pathol; 2017 Mar; 46(1):46-53. PubMed ID: 27874969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
    Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
    Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia.
    Parmeggiani L; Ferrant A; Rodhain J; Michaux JL; Sokal G
    Eur J Haematol; 1987 Sep; 39(3):228-32. PubMed ID: 3678474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
    Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
    Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary myelofibrosis with metastatic breast cancer simulating agnogenic myeloid metaplasia: report of a case and review of the literature.
    Yablonski-Peretz T; Sulkes A; Polliack A; Weshler Z; Okon E; Catane R
    Med Pediatr Oncol; 1985; 13(2):92-6. PubMed ID: 3982370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistopathological Analysis of Extramedullary Hematopoiesis and Angiogenesis of Spleen in a Case of Primary Myelofibrosis with Huge Splenomegaly.
    Kawano N; Saito N; Yoshida S; Kitanaka A; Shide K; Marutsuka K; Ohshima K; Shimoda K
    Tohoku J Exp Med; 2022 Feb; 256(2):119-125. PubMed ID: 35173090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-megakaryoblasts in bone marrow tissue from patients with primary (idiopathic) osteo-myelofibrosis (agnogenic myeloid metaplasia). An immunomorphometric study on trephine biopsies.
    Thiele J; Wagner S; Bertsch HP; Wienhold S; Fischer R; Dienemann D; Stein H; Zankovich R
    Pathol Res Pract; 1990 Oct; 186(5):589-96. PubMed ID: 2287586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
    Mesa RA; Li CY; Schroeder G; Tefferi A
    Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agnogenic myeloid metaplasia in children.
    Mallouh AA; Sa'di AR
    Am J Dis Child; 1992 Aug; 146(8):965-7. PubMed ID: 1636666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic megakaryocytopoiesis in primary (idiopathic) osteomyelofibrosis. An immunohistological and morphometric study with comparison of corresponding bone marrow features.
    Thiele J; Klein H; Falk S; Bertsch HP; Fischer R; Stutte HJ
    Acta Haematol; 1992; 87(4):176-80. PubMed ID: 1519432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An electron microscopic study of spleen in myelofibrosis with myeloid metaplasia.
    Tavassoli M; Weiss L
    Blood; 1973 Aug; 42(2):267-79. PubMed ID: 4793115
    [No Abstract]   [Full Text] [Related]  

  • 17. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.
    Thiele J; Hoeppner B; Zankovich R; Fischer R
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(3):191-202. PubMed ID: 2503923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell aplasia in myelofibrosis with myeloid metaplasia. A distinct functional and clinical entity.
    Barosi G; Baraldi A; Cazzola M; Spriano P; Magrini U
    Cancer; 1983 Oct; 52(7):1290-6. PubMed ID: 6192899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature.
    Coltro G; Mannelli F; Vergoni F; Santi R; Massi D; Siliani LM; Marzullo A; Bonifacio S; Pelo E; Pacilli A; Paoli C; Franci A; Calabresi L; Bosi A; Vannucchi AM; Guglielmelli P
    Clin Exp Med; 2020 May; 20(2):313-320. PubMed ID: 32065308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic myelofibrosis without splenomegaly.
    Cheng DS
    Cancer; 1979 May; 43(5):1761-5. PubMed ID: 445365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.